...
首页> 外文期刊>Blood pressure. >Agonist-like activity of antibodies to angiotensin II receptor subtype 1 (AT1) from rats immunized with AT1 receptor peptide.
【24h】

Agonist-like activity of antibodies to angiotensin II receptor subtype 1 (AT1) from rats immunized with AT1 receptor peptide.

机译:来自用AT1受体肽免疫的大鼠的血管紧张素II受体亚型1(AT1)的抗体的激动剂样活性。

获取原文
获取原文并翻译 | 示例

摘要

In the present study, rats were immunized with angiotensin II receptor subtype 1 (AT1) receptor peptides for 3 months to see if the immunization produced specific anti-AT1 receptor antibodies and if continuous stimulation for 3 months affected blood pressure or induced morphological changes in the organs containing AT1 receptors. Our results showed that there were constant high levels of circulating antibodies throughout the study period in all rats of the immunized group, but not in the control rats, and that there were almost no significant cross-reactions of antisera with AT2 receptor peptide and alpha1 adrenoceptor peptide, except in four rats, which showed low cross-reactions with alpha1 adrenoceptor and AT2 receptor peptides. When an affinity-purified anti-AT1 receptor antibody was used, it specifically displayed the AT1-stimulatory positive chronotropic effect and also localized AT1 receptors. However, in the immunized group, saturation binding of AT1 in homogenates from kidneys showed no difference either in maximal binding sites (Bmax) or in antagonist affinity (Kd). No difference in mRNA of AT1a was found in either kidney or heart, and no morphological changes in the organs were observed, as compared with the control group. Furthermore, immunization did not cause hypertension. In conclusion, the synthetic peptide corresponding to the second extra-cellular loop of the human AT1 receptor was able to produce highly specific and functionally active anti-AT1 receptor antibodies, but unable to induce pathological structural changes or hypertension.
机译:在本研究中,用血管紧张素II受体亚型1(AT1)受体肽免疫大鼠3个月,以观察免疫是否产生了特定的抗AT1受体抗体,并且连续3个月的刺激是否会影响血压或诱导小鼠的形态变化含有AT1受体的器官。我们的结果表明,在整个研究期间,免疫组的所有大鼠中均存在恒定水平的循环抗体,而对照大鼠中则没有,并且抗血清与AT2受体肽和α1肾上腺素受体的交叉反应几乎没有肽,除了在四只大鼠中显示出与alpha1肾上腺素受体和AT2受体肽的低交叉反应外。当使用亲和纯化的抗AT1受体抗体时,它特异性地表现出AT1刺激的正变时性作用,并且还局部化了AT1受体。但是,在免疫组中,来自肾脏的匀浆中AT1的饱和结合在最大结合位点(Bmax)或拮抗剂亲和力(Kd)上均没有差异。与对照组相比,在肾脏或心脏中均未发现AT1a mRNA的差异,并且未观察到器官的形态变化。此外,免疫接种不会引起高血压。总之,对应于人AT1受体第二个细胞外环的合成肽能够产生高度特异性和功能活跃的抗AT1受体抗体,但不能诱导病理结构改变或高血压。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号